Phenobarbital Effects in Cholestatic Liver Disease
Authors:
- Joseph R. BloomerJBJoseph R. Bloomer
- 1 March 1975
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 82 (3) , 310-317
Abstract
Fifteen patients with cholestatic disorders were treated for 1 to 5 months with phenobarbital. Primary biliary cirrhosis was diagnosed in seven, sclerosing cholangitis in two, intrahepatic biliary hypoplasia in three, and cholestatic hepatitis in three. Except for the patients with cholestatic hepatitis, in whom marked cholestasis was virtually the only abnormality in liver biopsy specimens, serum bilirubin and bile acid concentrations were diminished during therapy, the hepatic clearance of sulfobromophthalein and 131-I-rose bengal was variably enhanced, and there was relief from pruritus. Serum cholesterol concentrations and other measures of hepatic function were not significantly changed during therapy except for serum alkaline phosphatase activity, which rose in twelve patients. Parallel changes occurred in 5'-nucleotidase, suggesting a hepatic origin for the alkaline phosphatase activity. These studies indicate that phenobarbital therapy is associated with improvement in organic anion clearance in some patients with cholestatic disorders and may be beneficial to such patients.Keywords
This publication has 38 references indexed in Scilit:
- Effect of phenobarbitone on plasma and hepatic alkaline phosphatase activity in the dogNaunyn-Schmiedeberg's Archives of Pharmacology, 1972
- Changes in liver blood flow during enzyme inductionBiochemical Pharmacology, 1971
- Mechanism of CholestasisGastroenterology, 1971
- The role of the liver in drug metabolismThe American Journal of Medicine, 1970
- Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiencyThe American Journal of Medicine, 1969
- The effect of oral phenobarbitone on hepatic microsomal cytochrome P-450 and demethylation activity in rats fed normal and low protein dietsBiochemical Pharmacology, 1969
- The stimulation of liver growth and demethylase activity following phenobarbital treatmentDevelopmental Biology, 1968
- Enhanced formation of rapidly labeled bilirubin by phenobarbital: Hepatic microsomal cytochromes as a possible sourceBiochemical and Biophysical Research Communications, 1966
- The Long Term Use of Cholestyramine in the Treatment of Primary Biliary CirrhosisGastroenterology, 1965
- Relief of the Pruritus of Jaundice with a Bile-Acid Sequestering ResinJAMA, 1961